Platform Awards

For each ISOPP International Symposium, the top 10 abstracts are selected for presentation during the Platform Presentations session.

Presenting authors must be members of ISOPP and/or local host organization.

Please note that the detailed guidelines may vary for each Symposium. You can also view the Abstract Book from the previous Symposium in the Library.

See more details on the Award for ISOPP CAPhO 2025

2023

1. Eduard Fort, Spain
   Dose intensity of palbociclib and initial body weight dosage: implications on progression free survival in 220 patients with ER+/HER2-negative metastatic breast cancer
2. Maria Marchese, Canada
   Characteristics of Nirmatrelvir/Ritonavir (Paxlovid) Recipients and Clinical Interventions by Oncology Pharmacists at a Tertiary Outpatient Cancer Centre    
3. Tiene Bauters, Belgium
   Safe handling of non-carcinogenic drugs in the Ghent University Hospital: development, implementation and communication of hospital-specific guidelines    
4. Frédéric Feutry, France
   Infusion of Busulfan solution through closed safety connectors Qimomale© and Qimofemale©    
5. Héctor C. García-Díaz, Spain
   Case series: use of olaparib in uncommon locations in patients with impaired homologous recombination
6. Sandra Fontanals-Martínez, Spain
   Real-world data evaluation of medicines used in special situations in oncohematology: a retrospective study from a comprehensive cancer institution
7. L. Collada Sánchez, Spain
   Dostarlimab in the treatment of recurrent endometrial cancer: real life experience
8. Loreto Dominguez Senin, Spain
   Medication-related osteonecrosis of the jaws and CDK4/6 inhibitors in breast cancer
9. Maria Monro, UK
   Efficacy and safety outcomes of generic imatinib in adults with chronic myeloid leukaemia (CML) following the switch from branded imatinib
10. Rodrigo Spineli-Macedo, Brazil
    Reproducibility analysis of PRONTO, chemotherapy order verification checklist
     

2019

Chia Jie Tan, Singapore
Antineoplastic treatment and cognitive impairment among adolescent and young adult cancer patients

Note: For ISOPP 2019, Oral presentations were judged by the audience and the ISOPP and BOPA Research Committees. The best platform presentation was awarded a travel grant to an international conference of their choosing up to the amount of £2,000.

2018

1. Yi Long Toh, Singapore
   Characterizing the Incidence, Trajectory and Severity of Cancer-Related Fatigue (CRF) in Asian Breast Cancer Patients
2. Vivianne Shih, Singapore
   Determining the Usefulness of a Tele-Oncology Service to Aid in Medication Adherence, Early Detection and Management of Adverse Effects (AEs) to Oral Anticancer Therapies (OAT)
3. Irene Kraemer, Germany
   Robotic I.V. Medication Compounding: Recommendations from the International Community of APOTECAchemo Users
4. Russell Hill, Australia
   Implementation of a Quality Assurance Framework for Icon Group Oncology Pharmacy Practice Within Australia
5. Marius Youan Bi, Ivory Coast
   Evaluation of Intravenous Preloading Magnesium Supplementation as a Preventive Measure of Cisplatin Induced Nephrotoxicity
6. Shinya Suzuki, Japan
   Impact of an Interactive, Visual Flowchart-Type Leaflet for Cancer Chemotherapy Outpatients on Telephone Counseling Hotline
7. Himanshu Patel, India
   Improving Medicines Safety in Oncology Care: The Role of Prospective Surveillance by Clinical Pharmacists to Guide Changes in Clinical Practice
8. Chia Jie Tan, Singapore 
   Indirect Cost of Cancer Burden Among Breast Cancer Survivors After Treatment Completion in Singapore
9. Myer Lawrence, Saudi Arabia 
   Comparison of Closed System Transfer Devices (CSTDs) for Turnaround Time and Ease of Use
10. Alan Wilkinson, UK 
    Containment Performance Assessment of Closed System Drug Transfer Devices (CSTDs) Using the NIOSH Draft Protocol and TEU as Surrogate

2017

1. Racha Sabbagh Dit Hawasli, United Kingdom
   Towards the Safe Handling of Cytotoxic Drugs in Academic Research Settings; Recommendations from a Multidisciplinary Working Group
2. En Hui Phebe Si, Singapore
   Developing a Decision Support Tool to Assist Clinicians to Assess the Benefit of Palliative Chemotherapy in Stage 4 Breast Cancer Patients
3. Tine Van Nieuwenhuyse and Birgit Tans, Belgium
   Oral Anticancer Drugs: to Crush or Not to Crush
4. Shinya Suzuki, Japan
   Differences Between Online Survey and Mailed Survey from the Nationwide Survey for Community Pharmacists in Japan
5. Eskinder Eshetu Ali and Lita Chew, Singapore
   Patient Adherence to Oral Anticancer Medications in an Asian Tertiary Cancer Care Centre
6. Lauren Charbonneau, Canada
   Implementation of Camera Technology to Meet Traceability Standards for Compounded Sterile Products and Increase Efficiency in a Regional Cancer Centre
7. Lisa Holle, United States
   Oncology Dose-Rounding Program
8. Shinya Suzuki, Japan
   Characteristics and Management of High Incidence of Grade 3, 4 Hypertension in Lenvatinib Oral Chemotherapy for Thyroid Cancer Patients
9. Matteo Federici, Germany
   Efficacy of Four Cleaning Solutions for the Decontamination of Cytotoxic Drugs on Different Surfaces of the Automated Compounding System APOTECAchemo
10. Chenchia Lin, Taiwan
    Challenge the Compatibility of Closed System Transfer Devices with Multiple Chemotherapy Drugs